0001161697-22-000400.txt : 20220819
0001161697-22-000400.hdr.sgml : 20220819
20220819170319
ACCESSION NUMBER: 0001161697-22-000400
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220818
FILED AS OF DATE: 20220819
DATE AS OF CHANGE: 20220819
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Miller Steve
CENTRAL INDEX KEY: 0001402535
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33057
FILM NUMBER: 221181509
MAIL ADDRESS:
STREET 1: 220 MIRACLE MILE
STREET 2: SUITE 234
CITY: CORAL GABLES
STATE: FL
ZIP: 33134
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CATALYST PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001369568
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 355 ALHAMBRA CIRCLE
STREET 2: SUITE 801
CITY: CORAL GABLES
STATE: FL
ZIP: 33134
BUSINESS PHONE: (305) 529-2522
MAIL ADDRESS:
STREET 1: 355 ALHAMBRA CIRCLE
STREET 2: SUITE 801
CITY: CORAL GABLES
STATE: FL
ZIP: 33134
FORMER COMPANY:
FORMER CONFORMED NAME: CATALYST PHARMACEUTICAL PARTNERS, INC.
DATE OF NAME CHANGE: 20110215
FORMER COMPANY:
FORMER CONFORMED NAME: Catalyst Pharmaceutical Partners, Inc.
DATE OF NAME CHANGE: 20060719
4
1
form4.xml
FORM 4 FOR 08-18-2022
X0306
4
2022-08-18
0
0001369568
CATALYST PHARMACEUTICALS, INC.
CPRX
0001402535
Miller Steve
355 ALHAMBRA CIRCLE, SUITE 801
CORAL GABLES
FL
33134
0
1
0
0
Chief Operating Officer
Common stock, par value $0.001 per share
2022-08-18
4
M
0
118575
2.53
A
880299
D
Common stock, par value $0.001 per share
2022-08-18
4
S
0
118575
13.559
D
761724
D
Common stock, par value $0.001 per share
2022-08-18
4
M
0
31425
2.53
A
793149
D
Common Stock, par value $0.001 per share
2022-08-18
4
S
0
31425
13.434
D
761724
D
Options to purchase common stock
2.53
2022-08-18
4
A
0
118575
0
D
2022-12-30
Common Stock
118575
1492425
D
Options to purchase common stock
2.53
2022-08-18
4
A
0
31425
0
D
2022-12-30
Common Stock
31425
1461000
D
Shares were sold in various lots from $13.37 to $13.66 per share. The listed sales price represents a weighted average price for the shares sold.
Shares were sold in various lots from $13.30 to $13.54 per share. The listed sales price represents a weighted average price for the shares sold.
Shares were sold to cover exercise price of options, tax withholding requirements (if applicable) and for personal reasons. Shares were not sold as a result of any disagreement with the Company and Dr. Miller remains an officer of the Company.
Options vested in three annual tranches beginning on December 30, 2016.
/s/ Steve Miller
2022-08-19